Results for:(76 found)
Jan 3, 2014 10:58AM on Top StocksBy MoneyShow.com

A strong balance sheet and 42 years of rising dividends make this health care firm a low-risk buy.

Nov 4, 2013 10:27AM on Top StocksBy TheStreet.com Staff

The drug giant calms worries about its ability to innovate following its spinoff of Zoetis earlier this year.

Nov 1, 2013 9:18AM on Top StocksBy TheStreet.com Staff

JNJ's strong dividend yield of 2.9 percent and its attractive balance means investors won't die in waiting room.

Oct 18, 2013 9:37AM on Top StocksBy Jim Cramer

Look past the disappointments to find the value this season.

Oct 16, 2013 12:04PM on Top StocksBy Zacks.com

While the ultimate ramifications of a US default are nearly impossible to predict, these 3 picks should at least hold up much better than the overall market.

Oct 14, 2013 9:36AM on Top StocksBy TheStreet.com Staff

The company, which reports earnings Tuesday, needs to show better diversification and operational improvements.

Aug 21, 2013 3:28PM on Top StocksBy StreetAuthority

While investors often regard spinoffs as problem children, that stereotype doesn't fit this overlooked drugmaker. And you can profit from this.

Aug 19, 2013 3:00PM on Top StocksBy InvestorPlace

Coach, Express added to Greenblatt's value screen.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More